BioSpace News Archive

Policy

Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm

The Court ordered Onxeo to pay SpeBio for costs incurred before termination the sum of 8.6 million euros with capitalized interest at the legal rate as of June 30, 2014.

October 18, 2017
·
5 min read
Business

Pharmazz has Received Exclusive License to U.S. Patent for Treatment of Opioid Tolerance And Pain Management

Pharmazz has received exclusive license to U.S. patent for treatment of opioid tolerance and pain management. Inadequate pain control is a major public health concern in the USA.

October 18, 2017
·
2 min read
Policy

City Of Hope, Leading Cancer Research And Treatment Center, To Provide First-Ever FDA-Approved CAR-T Cell Therapy For Adult Patients With Certain Types Of Large B-Cell Lymphoma

City of Hope will be one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. Food and Drug Administration (FDA) announced today is the first approved CAR-T cell therapy.

October 18, 2017
·
5 min read
Policy

Allergan Issues Investor FAQ on Federal District Court RESTASIS Patent Decision

Allergan issued the FAQ document following the U.S. District Court’s decision on the RESTASIS patents announced earlier this week.

October 18, 2017
·
2 min read
Biotech Bay

Bonnie J. Addario Lung Cancer Foundation and International Association for the Study of Lung Cancer Award Johns Hopkins School of Medicine Researcher $300,000

The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the International Association for the Study of Lung Cancer (IASLC) today announced the winner of the $300,000 ALCF-IASLC Second Joint International Fellowship Award for The Early Detection of Lung Cancer.

October 18, 2017
·
5 min read
Ampio Announces Closing of Registered Direct Offering

Ampio today announced that it has closed it’s previously announced registered direct offering of 7,709,400 shares of common stock at a purchase price of $0.875 per share for gross proceeds of approximately $6.75M.

October 18, 2017
·
3 min read
GENEWIZ Launches Expanded Next Generation Sequencing Services Including Quick-Turn Amplicon-EZ and Long-Read Amplicon Sequencing at ASHG

ASHG17, Booth #323 -- Leading global genomics service provider, GENEWIZ, launches CLIA Sanger sequencing and new NGS amplicon sequencing, at booth #323 during The American Society of Human Genomics (ASHG) Annual Meeting.

October 18, 2017
·
3 min read
Biotech Beach

NuVasive Launches New 3D-Printed Porous Titanium Implant In Expanding Advanced Materials Science Portfolio

NuVasive today announced the launch of Modulus XLIF titanium implants.

October 18, 2017
·
4 min read